GlobalNewsSouth East Asia

Zeon Lifesciences Upgrades its Paonta Sahib Plant Enabled with AI and Industry 2.0 Automation

The firm will gain from this in terms of capacity improvement, a focused perspective on zero faults, zero waste, zero accidents, cost optimization, diverse clientele, and a greater ability to handle diverse clients and diverse demands of all dose forms.

Sharing is caring!

Zeon Lifesciences, an Indian nutraceutical and herbal product manufacturer upgrades its Paonta sahib plant enabled with AI and Industry 2.0 Automation for business growth and innovation with the goal of focusing on new innovations and research advancements in India’s nutraceutical industry.

New developments have occurred at the existing plant as a result of plant advancement, such as the implementation of ZEMANEX’s new operating model (Zeon Manufacturing Excellence- The New Way of Working), the formation of a new independent vertical: Manufacturing Compliance, the implementation of the new First Line Leader (FLL) concept for better accountability and responsibility, and so on.

The firm will gain from this in terms of capacity improvement, a focused perspective on zero faults, zero waste, zero accidents, cost optimization, diverse clientele, and a greater ability to handle diverse clients and diverse demands of all dose forms. Consequently, additional jobs will be created, for those with less than five years of work experience, changing the operating model, which includes the organizational structure; from top-heavy to bottom rich, creates better opportunities for them to be inducted as developed FLL members, where they can demonstrate their talent and leadership in leading blue-collar workers.

Expressing his views on the development, Suresh Garg, MD, and Founder, of Zeon Lifesciences, stated “To tackle the upcoming challenges of industrial expansion, research & development, and innovations in the nutraceutical sector, technology-enabled innovation and consistent adoption of new technologies are required. I think that this new development and the facilities at the plant will open up new opportunities for business, medical research, and innovation, as well as establish a standard for nutraceuticals in India. I have no doubt that this new business initiative will be a great success.”

“Zeon consistently promotes innovative and translational research in an effort to revolutionize medical innovation and research in India. The main goal of this development is to conduct out R&D projects that are easy to manage to study product formulation and its development in the areas of Nutraceuticals, Ayurvedic, Clinical Nutrition, Phytotherapeutics, Sports Nutrition and Cosmeceuticals” said Dr. Vivek Srivastav, Senior Vice President, Zeon Lifesciences

SMEStreet Edit Desk

SMEStreet Edit Desk is a small group of excited and motivated journalists and editors who are committed to building MSME ecosystem through valuable information and knowledge spread.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
%d bloggers like this: